Clinical Trial Update: Neurexan - a Clinical Trial in Short-Term Insomnia Patients [Phase 2]

View source ↗

Summary

Neurexan completed a Phase 2 trial investigating its use for short-term insomnia and stress reactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Stress Reaction

Drugs mentioned

• Neurexan

Snippet

Sponsor: Biologische Heilmittel Heel GmbH | Conditions: Insomnia, Stress Reaction | Phase 2 | Status: COMPLETED